Ionis Pharmaceuticals Inc. Common Stock vs RUM Group Inc. Class A Common Stock — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while RUM Group Inc. Class A Common Stock trades at $6.02 (market cap $2.68B). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 2.6× RUM Group Inc. Class A Common Stock's market cap, and RUM Group Inc. Class A Common Stock is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and RUM Group Inc. Class A Common Stock for 0 Days on average.
| IONS | RUM | |
|---|---|---|
Market Cap | $7.04B | $2.68B |
Volume | 2,977,440 | 3,201,203 |
Sector | Health | Media |
52-Week High | $86.50 | $10.23 |
52-Week Low | $42.38 | $4.67 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $2.98B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →RUM Group Inc., formerly Rumble Inc., is a holding company operating two business units: Rumble, an online video-sharing platform, and Quake AI, a cloud computing and artificial-intelligence infrastructure business.
Read more on RUM →